Browse by category

The oral GLP-1, orforglipron, can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by researchers from the University of Texas Health Science Center at Houston, TX. Orforglipron (Image credit: Jovan.gec) "The opportunity for an oral GLP-1 medication with highly effective weight loss that is simpler to take may provide increased access and opportunities fo

Results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron, an investigational oral glucagon-like...